Quantification in situ of crystalline cholesterol and calcium phosphate hydroxyapatite in human atherosclerotic plaques by solid-state magic angle spinning NMR

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1630-1636

  Guo, Wen ^a   Morrisett, Joel D ^b   DeBakey, Michael E ^b   Lawrie, Gerald M ^b   Hamilton, James A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerotic plaques; Calcium phosphate hydroxyapatite; Crystalline cholesterol; Magic angle spinning NMR; Phospholipids

Indexed keywords

HYDROXYAPATITE;

ANALYTIC METHOD; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARBON NUCLEAR MAGNETIC RESONANCE; CAROTID ENDARTERECTOMY; CELL ULTRASTRUCTURE; CHEMICAL ANALYSIS; CRYSTALLIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOLID STATE; X RAY DIFFRACTION;

EID: 0034048209     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1630     Document Type: Article

References (46)

1. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
2. Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol. 1996;16:4-11.
3. Fuster V, Badimon J, Chesehro JH, Fallon JT. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis. 1996,26(suppl 4:)269-284.
4. Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 1996;23: 755-765, discussion 765-766.
5. Kostulas K, Huang WX, Crisby M, Jin YP, He B, Lannfelt L, Eggertsen G, Kostulas V, Hillert J. An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur J Clin Invest. 1999;29:478-483.
6. Katz SS, Shipley GG, Small DM. Cholesterol turnover in lipid phases of human atherosclerotic plaque. J Lipid Res. 1982;23:733-737.
7. Small DM. George Lyman Duff memorial lecture: progression and regression of atherosclerotic lesions: insights from lipid physical biochemistry. Arteriosclerosis. 1988;8:103-129.
8. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions: demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest. 1976;58: 200-211.
9. Weinmann P, Jouan M, Dao NQ, Lacroix B, Groiselle C, Bonte J-P, Luc G. Quantitative analysis of cholesterol and cholesteryl esters in human atherosclerotic plaques using near-infrared Raman spectroscopy. Atherosclerosis. 1998;140:81-88.
10. Romer T, Brennan JF, Fitzmaurice M, Feld ML, Deinum G, Myles J, Kramer JR, Lees RS, Feld MS. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation. 1998;97:878-885.
11. Kramsch DM, Chan CT. The effect of agents interfering with soft tissue calcification and cell proliferation of calcific fibrous-fatty plaques in rabbits. Circ Res. 1978;42:562-571.
12. Kramsch DM, Aspen AJ, Rozler LJ. Atherosclerosis: prevention by agents not affecting abnormal levels of blood lipids. Science. 1981;213: 1511-1512.
13. Watson KE, Demer LL. The atherosclerosis-calcification link? Curr Opin Lipidol. 1996;7:101-104.
14. Wimpfheimer O, Haramati LB, Haramati N. Calcification of the ligamentum arteriosum in adults: CT features. J Comput Assist Tomogr. 1996;20:34-37.
15. Simon A, Giral P, Levenson J. Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men: association with coronary risk profile. Circulation. 1995;92: 1414-1421.
16. Moore JR, Garrido L, Ackerman JL. Solid state phosphorus-31 magnetic resonance imaging of bone mineral. Magn Reson Med. 1995;33:293-299.
17. Seeger JM, Barratt E, Lawson GA, Klingman N. The relationship between carotid plaque composition, plaque morphology, and neurologic symptoms. J Surg Res. 1995;58:330-336.
18. Schmid K, McSharry WO, Pameijer CH, Binette JP. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis. 1980;37:199-210.
19. Hamilton JA, Oppenheimer N, Cordes EH. Carbon-13 nuclear magnetic resonance studies of cholesteryl esters and cholesteryl ester/triglyceride mixtures. J Biol Chem. 1977;252:8071-8080.
20. 13C NMR spectroscopy. J Biol Chem. 1979;254:5435-5441.
21. 13C MAS NMR studies of crystalline cholesterol and lipid mixtures modeling atherosclerotic plaques. Biophys J. 1996;71: 2857-2868.
22. 1H magic angle spinning NMR study. Biochemistry. 1993;32:9038-9052.
23. Guo W, Morrisett JD, Lawrie GL, DeBakey ME, Hamilton JA. Identification of different lipid phases and calcium phosphate deposits in human carotid artery plaques by MAS NMR spectroscopy. Magn Reson Med. 1998;39:184-189.
24. Husted C, Montez B, Le C, Moscarello MA, Oldfield E. Carbon-13 "magic-angle" sample-spinning nuclear magnetic resonance studies of human myelin, and model membrane systems. Magn Reson Med. 1993; 29:168-178.
25. Pearse AGE. Histochemistry: Theoretical and Applied, Volume 1: Preparative and Optical Technology. 4th ed. London, England; Churchill Livingstone; 1980:250.
26. Yeagle PL, Hutton WC, Huang C, Martin RB. Phospholipid head-group conformations: intermolecular interactions and cholesterol effects. Biochemistry. 1977;16:4344-4349.
27. Frank A. Some developments and applications of microfocus X-ray diffraction techniques. Br J Appl Phys. 1958;9:349-352.
28. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226: 497-509.
29. Tercyak AM. Determination of cholesterol and cholesteryl esters. J Nutr Biochem. 1991;2:281-292.
30. Pinter JK, Hayashi JA, Watson JA. Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde. Arch Biochem Biophys. 1967;121: 404-414.
31. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem. 1959;234:466-468.
32. Nolte CJ, Tercyak AM, Wu HM, Small DM. Chemical and physiochemical comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterol-fed New Zealand White and Watanabe Heritable Hyperlipidemic rabbits. Lab Invest. 1990;62: 213-222.
33. Chao FF, Blanchette-Mackie EJ, Chen YJ, Dickens BF, Berlin E, Amende LM, Skarlatos SI, Gamble W, Resau JH, Mergner WT. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions. Am J Pathol. 1990;136:169-179.
34. Shipley GG, Avecilla LS, Small DM. Phase behavior and structure of aqueous dispersions of sphingomyelin. J Lipid Res. 1974;15:124-131.
35. Katz S, Small DM. Isolation and partial characterization of the lipid phases of human atherosclerotic plaques. J Biol Chem. 1980;255: 9753-9759.
36. North BE, Katz SS, Small DM. The dissolution of cholesterol monohydrate crystals in atherosclerotic plaque lipids. Atherosclerosis. 1978; 30:211-217.
37. 13C NMR studies of certain normal and abnormal human plasma lipoproteins. Science. 1976;194:1424-1427.
38. 13C-NMR spectroscopy of human atherosclerotic lesions: relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction. Arterioscler Thromb. 1994;14:1951-1957.
39. Guo W, Hamilton JA. Phase behavior and crystalline structures of cholesteryl ester mixtures: a C-13 MASNMR study. Biophys J. 1995;68: 2376-2386.
40. Fuster V. Mechanisms of arterial thrombosis: foundation for therapy. Am Heart J. 1998;135:S361-S366.
41. Bourges M, Small DM, Dervichian DG. Biophysics of lipidic associations, II: the ternary systems: cholesterol-lecithin-water. Biochim Biophys Acta. 1967;137:157-167.
42. Chao F-F, Blanchette-Mackie EJ, Dickens BF, Gamble W, Kruth HS. Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed NZW rabbits. J Lipid Res. 1994;35:71-83.
43. Anderson HC. Calcific diseases: a concept. Arch Pathol Lab Med. 1983; 107:341-348.
44. Tiselius A, Hjerten S, Levin O. Protein chromatography on calcium phosphate columns. Arch Biochem Biophys. 1956;65:132-155.
45. Brennan JF, Romer TJ, Lees RS, Tercyak AM, Kramer JR Jr, Feld MS. Determination of human coronary artery composition by Raman spectroscopy. Circulation. 1997;96:99-105.
46. Guo W, Hamilton JA. A multinuclear solid-state NMR study of phospholipid-cholesterol interactions: dipalmitoylphosphatidylcholine-cholesterol binary system. Biochemistry. 1995;34:14174-14184.